These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16217848)

  • 1. A multiscale method for disease mapping in spatial epidemiology.
    Louie MM; Kolaczyk ED
    Stat Med; 2006 Apr; 25(8):1287-306. PubMed ID: 16217848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiscale detection of localized anomalous structure in aggregate disease incidence data.
    Louie MM; Kolaczyk ED
    Stat Med; 2006 Mar; 25(5):787-810. PubMed ID: 16453373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian disease mapping using product partition models.
    Hegarty A; Barry D
    Stat Med; 2008 Aug; 27(19):3868-93. PubMed ID: 18381710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial variation of mortality for common and rare cancers in Piedmont, Italy, from 1980 to 2000: a Bayesian approach.
    Maule M; Merletti F; Mirabelli D; La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):108-16. PubMed ID: 16523007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple testing on standardized mortality ratios: a Bayesian hierarchical model for FDR estimation.
    Ventrucci M; Scott EM; Cocchi D
    Biostatistics; 2011 Jan; 12(1):51-67. PubMed ID: 20577014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The misuse of count data aggregated over time for disease mapping.
    Ocaña-Riola R
    Stat Med; 2007 Oct; 26(24):4489-504. PubMed ID: 17335121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation in Bayesian disease mapping.
    MacNab YC; Farrell PJ; Gustafson P; Wen S
    Biometrics; 2004 Dec; 60(4):865-73. PubMed ID: 15606406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling disease incidence data with spatial and spatio temporal dirichlet process mixtures.
    Kottas A; Duan JA; Gelfand AE
    Biom J; 2008 Feb; 50(1):29-42. PubMed ID: 17926327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivariate CAR model for improving the estimation of relative risks.
    Greco FP; Trivisano C
    Stat Med; 2009 May; 28(12):1707-24. PubMed ID: 19308933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An innovative application of Bayesian disease mapping methods to patient safety research: a Canadian adverse medical event study.
    MacNab YC; Kmetic A; Gustafson P; Sheps S
    Stat Med; 2006 Dec; 25(23):3960-80. PubMed ID: 16498611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian hierarchical model for the estimation of two incomplete surveillance data sets.
    Buenconsejo J; Fish D; Childs JE; Holford TR
    Stat Med; 2008 Jul; 27(17):3269-85. PubMed ID: 18314934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical Bayes estimation of small area prevalence of non-rare conditions.
    Martuzzi M; Elliott P
    Stat Med; 1996 Sep 15-30; 15(17-18):1867-73. PubMed ID: 8888479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mixture models for identifying high risks in disease mapping.
    Militino AF; Ugarte MD; Dean CB
    Stat Med; 2001 Jul; 20(13):2035-49. PubMed ID: 11427958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of conditional autoregressive models used in Bayesian disease mapping.
    Lee D
    Spat Spatiotemporal Epidemiol; 2011 Jun; 2(2):79-89. PubMed ID: 22749587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping disability-adjusted life years: a Bayesian hierarchical model framework for burden of disease and injury assessment.
    MacNab YC
    Stat Med; 2007 Nov; 26(26):4746-69. PubMed ID: 17427183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.
    McMahon PM; Zaslavsky AM; Weinstein MC; Kuntz KM; Weeks JC; Gazelle GS
    Med Decis Making; 2006; 26(5):497-511. PubMed ID: 16997927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian analysis of crossclassified spatial data with autocorrelation.
    Sun L; Clayton MK
    Biometrics; 2008 Mar; 64(1):74-84. PubMed ID: 17680834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient mapping of California mortality fields at different spatial scales.
    Choi KM; Serre ML; Christakos G
    J Expo Anal Environ Epidemiol; 2003 Mar; 13(2):120-33. PubMed ID: 12679792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling disease-state transition heterogeneity through Bayesian variable selection.
    Healy BC; Engler D
    Stat Med; 2009 Apr; 28(9):1353-68. PubMed ID: 19206077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.